New approach promising against multiple sclerosis
By Will Dunham
WASHINGTON (Reuters) - Treatment with an immune-suppressing drug may help people with the incurable disease multiple sclerosis, researchers said on Monday.
Their small study showed that treatment with high doses of cyclophosphamide, a generic cancer drug that has been around for half a century, cut the level of disability in MS patients, improved their physical functioning and reduced the number of brain lesions related to the condition.
Nine patients were tracked for two years after getting the drug. Five of them had no signs of disease activity, and the other four showed dramatic improvement, said Dr. Douglas Kerr of Johns Hopkins University in Baltimore.